about
Roles of PTEN with DNA Repair in Parkinson's DiseaseComputational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic AnalysisNeuronal dark matter: the emerging role of microRNAs in neurodegenerationPharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesLRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson's Disease.Mutations in the ATP13A2 gene and Parkinsonism: a preliminary review.Eryptosis as a marker of Parkinson's diseaseAnalysis of Thr12Met and Ala1144Thr mutations of the ATP13A2 gene in Parkinson's disease patients in Xinjiang Uygur and Han ethnic groups.Therapeutic perspectives of epigenetically active nutrients.Meta-Analysis of Parkinson's Disease Transcriptome Data Using TRAM Software: Whole Substantia Nigra Tissue and Single Dopamine Neuron Differential Gene Expression.Quantitation of hydrogen peroxide fluctuations and their modulation of dopamine dynamics in the rat dorsal striatum using fast-scan cyclic voltammetry.A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.Parkinson's Disease: From Pathogenesis to PharmacogenomicsCerebrospinal fluid biomarker candidates for parkinsonian disorders.Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases.Circulating miRNAs as biomarkers for neurodegenerative disorders.The potential of epigenetic therapies in neurodegenerative diseasesEpigenetic mechanisms in neurological and neurodegenerative diseases.Integrative biomarker discovery in neurodegenerative diseases.Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders.Implications of DNA Methylation in Parkinson's Disease.Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.Acute exposure to a Mn/Zn ethylene-bis-dithiocarbamate fungicide leads to mitochondrial dysfunction and increased reactive oxygen species production in Caenorhabditis elegans.Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone.The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.Physical activity in the prevention of human diseases: role of epigenetic modifications.Vertebrate food products as a potential source of prion-like α-synuclein.Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells.The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.Circulating microRNAs in Neurodegenerative Diseases.Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations.An Ontology Systems Approach on Human Brain Expression and Metaproteomics.Acetylome in Human Fibroblasts From Parkinson's Disease Patients.Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients.Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson's Disease DataStratifying Heterogeneous Dimension of Neurodegenerative Diseases: Intervention for Stipulating Epigenetic Factors to Combat Oxidative Stress in Human BrainA Comprehensive Analysis of the Association Between Polymorphisms and the Risk of Parkinson's DiseaseEpigenetic Study in Parkinson's Disease: A Pilot Analysis of DNA Methylation in Candidate Genes in Brain
P2860
Q26744483-BE58A62F-E854-4226-AC33-708EE610173FQ26774368-FC71855D-868E-443F-873D-B1BC24E89428Q26859224-E96E9558-C5A1-42B2-978A-82D9B788E520Q28088705-ECB84C70-330E-4373-9485-E4221B23B5B2Q33561039-4B09291D-B268-4955-8DCA-3BF4BB0CF173Q34100399-E37115DE-2BC4-4290-87C2-AEC79A30CEAEQ34585744-D3B301CD-BB20-4D4D-8FA0-E867784C1BEAQ34992975-5ADFD204-4F1E-4A65-BB02-7815F0094C98Q35631468-1AB596EE-EC81-4B27-A9AE-F35B75AF1764Q36128123-8531243F-9DDF-4543-BBFB-94B735EC6D2BQ36851676-5307221F-A50D-4033-95B4-8CC49B53F0EEQ37323166-E36F9BA7-7EA3-47B0-9EE7-9CAB73D942D3Q37729129-AB625A90-6B0B-452D-82D7-6F0EDD268C89Q38076411-A1D2EADF-A692-4780-82D5-30A17AD89195Q38095350-B60E5263-8769-449C-AD1A-CE9234F82C54Q38214427-0D26339A-D2D1-4A82-9250-AC074529A447Q38234971-BE2B0837-E573-4728-A9DA-F1B4C7BD254CQ38379396-977240D8-ECA4-4B06-AE5A-621B9BC6AE7DQ38542025-3AEDB64E-5B40-4FE1-84D8-98E1654A2744Q38584755-28A2B70E-30E7-44DA-B8F0-713492E2F0C6Q38645698-8CBC0125-EBB8-4C9E-B7AA-7EAF6F6895B1Q39273083-AB67673F-1F25-4DFA-B72B-912D16C40A83Q39355888-ED7D4334-D7CC-4A97-82E0-62842ECCE738Q42083792-E0601A10-3A9E-4A1C-A53E-42F868051EB8Q42355152-6D020687-CF17-455D-884B-0BECAB0E2DB2Q45397285-975239A2-E76B-4765-9E52-7E87CF7E2C30Q46252338-11D2EC35-7C33-4B5C-AEEC-33C637B471EFQ46283329-A3702599-AE5F-4F18-978E-1B8B0FAFD7DBQ46624520-6EF14D7B-EC06-4E1F-BB12-D9F5F58C5464Q48713195-F2697F32-0894-47EA-9BC5-AF9A2B41CE6EQ50243204-6F45A927-D31E-40A9-86BE-376C3ACD1D58Q52641621-459CAE4F-BE1E-45B9-B57D-2CE8BBEE203CQ54112963-F1BE3568-9D23-4785-A1DF-2E6FFC818AACQ54159456-062C84E8-270D-4461-B621-ACFA386A2A04Q55004951-1C142CC2-7A17-4B15-95D9-206F55D27B4FQ56381130-17396C9D-7C9B-4BFB-BD99-366B7A6E605FQ58051863-10251940-3B16-413B-A957-D6FB6F007CB3Q58556450-CEC19D75-BDEC-4B64-9428-847AB7C72175Q58693508-ADE95281-6EE3-4285-AD08-AFEEB8AD61FE
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Genetics and epigenetics of Parkinson's disease.
@en
Genetics and epigenetics of Parkinson's disease.
@nl
type
label
Genetics and epigenetics of Parkinson's disease.
@en
Genetics and epigenetics of Parkinson's disease.
@nl
prefLabel
Genetics and epigenetics of Parkinson's disease.
@en
Genetics and epigenetics of Parkinson's disease.
@nl
P2860
P356
P1476
Genetics and epigenetics of Parkinson's disease.
@en
P2093
Fabio Coppedè
P2860
P304
P356
10.1100/2012/489830
P407
P577
2012-05-01T00:00:00Z